NBT-NM108

· Notitia Biotechnologies Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NBT-NM108, covering 2024-10-08 to 2024-10-08. Get the full timeline:

Most recent: Clinical Trial Update: NBT-NM108 as an Early Treatment for Suspected or Confirmed Symptomatic COVID-19 Patients [Phase 2]